naringenin has been researched along with Chlamydia Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buendía, AJ; Del Río, L; García-Conesa, MT; Salinas, J | 1 |
| Dennis, VA; Morici, L; Singh, SR; Yilma, AN | 1 |
2 other study(ies) available for naringenin and Chlamydia Infections
| Article | Year |
|---|---|
The inhibitory effect of flavonoids and their gut-derived metabolites on the replication of Chlamydia abortus in the AH-1 ovine trophoblast cell line.
Topics: Animals; Anti-Bacterial Agents; Apigenin; Cell Line; Chlamydia; Chlamydia Infections; Female; Flavanones; Sheep; Sheep Diseases; Sheep, Domestic; Trophoblasts | 2019 |
Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chlamydia Infections; Chlamydia trachomatis; Flavanones; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; Immunologic Factors; Interleukin-10; Interleukin-1alpha; Interleukin-1beta; Interleukin-6; Macrophages; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Real-Time Polymerase Chain Reaction; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2013 |